DARATUMUMAB AS A TREATMENT FOR ADULT IMMUNE THROMBOCYTOPENIA: A PHASE II STUDY WITH SAFETY RUN-IN (THE DART STUDY)

G. Tsykunova, P. A. Holme, H. Thi Thyuet Tran, T. H. A. Tvedt, L. Munthe, M. Michel, H. Frederiksen, J. Bussel, D. Kuter, W. Ghanima

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article numberPB2313
JournalHemaSphere
Volume6
Issue numberSuppl. 3
Pages (from-to)2182-2183
ISSN2572-9241
DOIs
Publication statusPublished - 2022
EventEHA 2022 Hybrid Congress - Vienna, Austria
Duration: 9. Jun 202212. Jun 2022

Conference

ConferenceEHA 2022 Hybrid Congress
Country/TerritoryAustria
CityVienna
Period09/06/202212/06/2022

Cite this